Search by Drug Name or NDC
NDC 70010-0021-05 POTASSIUM CHLORIDE EXTENDED RELEASE 600 mg/1 Details
POTASSIUM CHLORIDE EXTENDED RELEASE 600 mg/1
POTASSIUM CHLORIDE EXTENDED RELEASE is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Granules Pharmaceuticals Inc.. The primary component is POTASSIUM CHLORIDE.
MedlinePlus Drug Summary
Potassium is essential for the proper functioning of the heart, kidneys, muscles, nerves, and digestive system. Usually the food you eat supplies all of the potassium you need. However, certain diseases (e.g., kidney disease and gastrointestinal disease with vomiting and diarrhea) and drugs, especially diuretics ('water pills'), remove potassium from the body. Potassium supplements are taken to replace potassium losses and prevent potassium deficiency. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 70010-0021-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Potassium
Product Information
| NDC | 70010-0021 |
|---|---|
| Product ID | 70010-021_f33d5a34-e5e7-a85f-e053-2995a90a6db3 |
| Associated GPIs | 79700030000420 |
| GCN Sequence Number | 001278 |
| GCN Sequence Number Description | potassium chloride TABLET ER 8 MEQ ORAL |
| HIC3 | C1D |
| HIC3 Description | POTASSIUM REPLACEMENT |
| GCN | 03514 |
| HICL Sequence Number | 000549 |
| HICL Sequence Number Description | POTASSIUM CHLORIDE |
| Brand/Generic | Generic |
| Proprietary Name | POTASSIUM CHLORIDE EXTENDED RELEASE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | POTASSIUM CHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 600 |
| Active Ingredient Units | mg/1 |
| Substance Name | POTASSIUM CHLORIDE |
| Labeler Name | Granules Pharmaceuticals Inc. |
| Pharmaceutical Class | Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211797 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70010-0021-05 (70010002105)
| NDC Package Code | 70010-021-05 |
|---|---|
| Billing NDC | 70010002105 |
| Package | 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (70010-021-05) |
| Marketing Start Date | 2020-10-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |